biotech

We understand that companies who specialize in the life sciences are in a field that is constantly changing and evolving; so we work with our clients to not just keep pace, but to set it.

LIFE SCIENCES & TECHNOLOGY

Over 370,000 workers are employed by Montgomery County's 30,400 high-tech businesses, in industries such as biotechnology, information technology, software development, telecommunications, and aerospace engineering. The county has over 200 biotech companies and industry leaders, making the state's biotech community the fourth largest in the nation.

Biotech has rebounded from the recession faster than most other industries in Maryland, so being home to about 8% of the biotech companies in the nation, the future of Maryland’s tech scene is bright. However there is still extraordinary pressure to deliver products that will save or enhance the lives and well-being of consumers while facing increasing regulation, escalating R&D costs, growing pricing concerns and decreasing financing.

For the more than 1,800 local, private-sector IT and telecommunications companies whose business is driven by data, emerging technologies, fierce competition and increasing consumer demands for innovative new products have fundamentally changed the industry. Accessing capital, implementing better business models and attracting and retaining the right talent are more important than ever. Companies who are adept at managing change, keeping up with consumer demands and harnessing rapidly evolving technology will prevail.

Consequently, having the right advisor to turn to for critical insights and innovative solutions to complex business issues is of paramount importance. Whether it's evaluating a project's long-term financial costs and benefits, obtaining patent and trademark assistance, improving operations or gaining perspective on the marketplace, Neimat Kuchman is especially focused on issues that impact small to mid-size life sciences and technology companies struggling to remain viable.

services

accounting procedural review

cash flow management

r&d tax incentive review

valuations

operational review

billing & collection procedures

biotech